Nonoperating Income (Expense) in USD of BioCorRx Inc. from 2014 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
BioCorRx Inc. quarterly/annual Nonoperating Income (Expense) history and change rate from 2014 to Q3 2025.
  • BioCorRx Inc. Nonoperating Income (Expense) for the quarter ending 30 Sep 2025 was $1.14M, a 675% increase year-over-year.
  • BioCorRx Inc. Nonoperating Income (Expense) for the twelve months ending 30 Sep 2025 was $1.16M.
  • BioCorRx Inc. annual Nonoperating Income (Expense) for 2024 was -$89.6K, a 618% decline from 2023.
  • BioCorRx Inc. annual Nonoperating Income (Expense) for 2023 was $17.3K, a 94.6% decline from 2022.
  • BioCorRx Inc. annual Nonoperating Income (Expense) for 2022 was $321K, a 7.24% increase from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)

BioCorRx Inc. Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $1.16M $1.14M +$990K +675% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025
Q2 2025 $167K $36.6K -$98.7K -72.9% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025
Q1 2025 $265K $86.2K +$355K 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025
Q4 2024 -$89.6K -$103K +$43.4K +29.7% 01 Oct 2024 31 Dec 2024 10-K 31 Mar 2025
Q3 2024 -$133K $147K +$52.2K +55.2% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025
Q2 2024 -$185K $135K +$112K +480% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025
Q1 2024 -$297K -$269K -$315K -688% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025
Q4 2023 $17.3K -$146K -$169K -741% 01 Oct 2023 31 Dec 2023 10-K 31 Mar 2025
Q3 2023 $186K $94.5K +$16.4K +21% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024
Q2 2023 $170K $23.4K -$17.2K -42.4% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024
Q1 2023 $187K $45.7K -$134K -74.6% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024
Q4 2022 $321K $22.8K -$109K -82.6% 01 Oct 2022 31 Dec 2022 10-K 01 Apr 2024
Q3 2022 $430K $78.1K -$193K -71.2% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023
Q2 2022 $623K $40.5K +$139K 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023
Q1 2022 $484K $180K +$185K 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023
Q4 2021 $299K $131K -$731K -84.8% 01 Oct 2021 31 Dec 2021 10-K 31 Mar 2022
Q3 2021 $1.03M $271K -$996K -78.6% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 $2.03M -$98.5K -$1.51M -107% 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022
Q1 2021 $3.54M -$4.85K -$444K -101% 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022
Q4 2020 $3.99M $863K +$470K +120% 01 Oct 2020 31 Dec 2020 10-K 31 Mar 2022
Q3 2020 $3.52M $1.27M +$1.42M 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021
Q2 2020 $2.1M $1.42M +$1.86M 01 Apr 2020 30 Jun 2020 10-Q 13 Aug 2021
Q1 2020 $243K $439K +$730K 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021
Q4 2019 -$487K $392K +$922K 01 Oct 2019 31 Dec 2019 10-K 31 Mar 2021
Q3 2019 -$1.41M -$148K +$337K +69.5% 01 Jul 2019 30 Sep 2019 10-Q 16 Nov 2020
Q2 2019 -$1.75M -$441K +$39.1K +8.14% 01 Apr 2019 30 Jun 2019 10-Q 14 Aug 2020
Q1 2019 -$1.79M -$290K +$173K +37.3% 01 Jan 2019 31 Mar 2019 10-Q 15 May 2020
Q4 2018 -$1.96M -$530K +$13.6K +2.51% 01 Oct 2018 31 Dec 2018 10-K 30 Mar 2020
Q3 2018 -$1.97M -$485K -$46.9K -10.7% 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2019
Q2 2018 -$1.93M -$480K -$12.6M -104% 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2019
Q1 2018 $10.6M -$463K +$37.5M +98.8% 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019
Q4 2017 -$26.8M -$544K +$231K +29.9% 01 Oct 2017 31 Dec 2017 10-K 16 Apr 2019
Q3 2017 -$27M -$438K +$1.65M +79% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018
Q2 2017 -$28.7M $12.1M +$12.8M 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2018
Q1 2017 -$41.5M -$37.9M -$37.7M -19455% 01 Jan 2017 31 Mar 2017 10-Q 18 May 2018
Q4 2016 -$3.72M -$775K -$1.48M -210% 01 Oct 2016 31 Dec 2016 10-K 05 Apr 2018
Q3 2016 -$2.25M -$2.09M -$1.9M -994% 01 Jul 2016 30 Sep 2016 10-Q 14 Nov 2017
Q2 2016 -$345K -$661K -$798K -583% 01 Apr 2016 30 Jun 2016 10-Q 11 Aug 2017
Q1 2016 $453K -$194K +$1.58K +0.81% 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017
Q4 2015 $452K $702K 01 Oct 2015 31 Dec 2015 10-K 13 Apr 2017
Q3 2015 -$191K 01 Jul 2015 30 Sep 2015 10-Q 17 Nov 2016
Q2 2015 $137K 01 Apr 2015 30 Jun 2015 10-Q 17 Aug 2016
Q1 2015 -$196K 01 Jan 2015 31 Mar 2015 10-Q 23 May 2016

BioCorRx Inc. Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$89.6K -$107K -618% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025
2023 $17.3K -$304K -94.6% 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025
2022 $321K +$21.7K +7.24% 01 Jan 2022 31 Dec 2022 10-K 01 Apr 2024
2021 $299K -$3.69M -92.5% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2022
2020 $3.99M +$4.47M 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022
2019 -$487K +$1.47M +75.1% 01 Jan 2019 31 Dec 2019 10-K 31 Mar 2021
2018 -$1.96M +$24.9M +92.7% 01 Jan 2018 31 Dec 2018 10-K 30 Mar 2020
2017 -$26.8M -$23.1M -620% 01 Jan 2017 31 Dec 2017 10-K 16 Apr 2019
2016 -$3.72M -$4.17M -924% 01 Jan 2016 31 Dec 2016 10-K 05 Apr 2018
2015 $452K +$527K 01 Jan 2015 31 Dec 2015 10-K 13 Apr 2017
2014 -$75.2K 01 Jan 2014 31 Dec 2014 10-K 14 Apr 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.